High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule Screening

Steven A Haney1

  • 1Cancer Biology and the Tumor Microenvironment, Discovery Oncology, Lilly Research Laboratories/Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, 46285, USA. haney_steven_a@lilly.com.

Summary

Screening libraries of small molecules aids biological investigation but faces reagent specificity challenges. Image-based screening offers advanced methods to distinguish specific cellular effects, improving research accuracy.